Followers | 375 |
Posts | 16984 |
Boards Moderated | 4 |
Alias Born | 03/07/2014 |
Saturday, February 07, 2015 10:45:40 PM
Yup, also the one lacking licenses and patent protections- who's gonna wanna partner on that? "potential" partners with "potential" being the operative word IMO. I can go back and grab YEARS of BHRT "PR" releases specking of "potential partners" and "term sheets" being signed and "financing that's close" (that never materialized) and of course, the gradn daddy of um all for me personally, the "MIRROR PHASE 3 TRIAL, FULLY FUNDED BY BIOHEART" ole "PR", all except the pesky little detailed part where it NEVER ACTUALLY HAPPENED and was thus NEVER FULLY FUNDED BY BIOHEART. YUP.
From the Bioheart 10-K filing, PAGE 13:
"Our MyoCell SDF-1 product candidate, which has recently completed preclinical testing, is intended to be an improvement to MyoCell. In February 2006, we signed a patent licensing agreement with the Cleveland Clinic of Cleveland, Ohio which gave us exclusive license rights to pending patent applications in connection with MyoCell SDF-1. Dr. Marc Penn, the Medical Director of the Cardiac Intensive Care Unit at the Cleveland Clinic and a staff cardiologist in the Departments of Cardiovascular Medicine and Cell Biology, joined our Scientific Advisory Board. The license for SDF-1 was passed on to a Cleveland Clinic affiliate, Juventas, in July of 2009. Bioheart has an understanding with Juventas pursuant to which the license with Bioheart will be reinstated upon completion of certain financial milestones."
CLASSIC BHRT wording IMO. They have an "understanding"??? What does that even mean? Is it in writing? Is it a handshake? Is it verbal? WHAT are the so called "completion of certain financial milestones" that then need to be met- for BHRT to even have license again to use ole SDF-1, another item they didn't invent but only license from someone else- that license now apparently passed to some company called "Juventas".
Another vague statement- and one is to believe they can "partner" with someone on a product to which it appears they don't even hold the licensing rights, per their own 10-K statements? I'd love to know how exactly that one's gonna work? Fascinating again IMO.
From this "Juventas" firm's own website- it sure looks like they think they are working on SDF-1 IMO?
http://juventasinc.com/sdf1.html
http://juventasinc.com/clinical-trials.html
http://juventasinc.com/team.html
http://juventasinc.com/board.html
http://juventasinc.com/partners.html
They, this Juventas has SDF-1 "heart" stuff plastered all over their website and Cleveland Clinic listed as a "partner", who according to the BHRT 10-K is the originator of the SDF-1 licensing and patent rights from the way I read that 10-K paragraph above. So how is BHRT then going to use it, test it, run trials on it, etc- if BHRT doesn't even own the rights to it possibly??
I don't get it? Vague and confusing as usual IMO.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM